Insulin Receptor in Pancreatic Cancer—Crown Witness in Cross Examination

Insulin Receptor in Pancreatic Cancer—Crown Witness in Cross Examination

Background: The proximity of pancreatic cancer (PDAC) to the physiological source of the growth promoting hormone insulin might be exploited by this highly malignant cancer entity. We investigated if (I) PDACs express the insulin receptor (IR) in cancer cells and cancer vasculature, (II) if IR corre...

Full description

Bibliographic Details
Main Authors: Steffen M. Heckl, Lukas Kercher, Samir Abdullazade, Carolin Schneider, Sandra Krüger, Hans-Michael Behrens, Susanne Sebens, Heiner Schäfer, Stefan Schreiber, Christoph Röcken
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cancers
Subjects:
insulin receptor
pancreatic cancer
insulin
IGF1 receptor
prognosis
Online Access:https://www.mdpi.com/2072-6694/13/19/4988

Internet

https://www.mdpi.com/2072-6694/13/19/4988

Similar Items